Feasibility of Inpatient Continuous Glucose Monitoring During the COVID-19 Pandemic: Early Experience
Diabetes Care
.
2020 Oct;43(10):e137-e138.
doi: 10.2337/dc20-1503.
Epub 2020 Aug 7.
Authors
Sirimon Reutrakul
1
,
Matthew Genco
2
,
Harley Salinas
3
,
Robert M Sargis
3
,
Carlie Paul
3
,
Yuval Eisenberg
3
,
Jiali Fang
2
,
Rachel N Caskey
2
,
Sarah Henkle
4
,
Sam Fatoorehchi
4
,
Amanda Osta
2
5
,
Pavan Srivastava
2
5
,
Alexia Johnson
6
,
Sarah E Messmer
2
5
,
Michelle Barnes
2
5
,
Sarida Pratuangtham
7
,
Brian T Layden
3
Affiliations
1
Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, University of Illinois at Chicago, Chicago, IL sreutrak@uic.edu.
2
Department of Medicine, University of Illinois at Chicago, Chicago, IL.
3
Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, University of Illinois at Chicago, Chicago, IL.
4
Department of Family Medicine, University of Illinois at Chicago, Chicago, IL.
5
Department of Pediatrics, University of Illinois at Chicago, Chicago, IL.
6
University of Illinois Hospital & Health Sciences System, Chicago, IL.
7
California Institute of Technology, Pasadena, CA.
PMID:
32769129
PMCID:
PMC7876554
DOI:
10.2337/dc20-1503
No abstract available
Publication types
Letter
Research Support, Non-U.S. Gov't
Grants and funding
P30 DK020595/DK/NIDDK NIH HHS/United States